Drugs / Buprenorphine/Naloxone
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07314346 | Jan 2025 → Aug 2026 overdue | — | Atea Pharmaceuticals, Inc. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Buprenorphine/Naloxone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07314346 ↗ |